Martin Diggle

Martin Henry Diggle founded Vulpes Investment Management Ltd., where he is working as Director & Partner from 2015.
Mr. Diggle also currently works at Vulpes Life Sciences Fund, as Chairman, Proteome Sciences Plc, as Non-Executive Director from 2014, Oxford BioDynamics Plc, as Non-Executive Director from 2026, and Vulpes Ventures, as Portfolio Manager.
Mr. Diggle also formerly worked at Oxford Biomedica Plc, as Non-Independent Non-Executive Director from 2012 to 2021, Brunswick UBS, as Director & Partner, Scancell Holdings Plc, as Non-Executive Director, Leucid Bio Ltd., as Director, and Chronos Therapeutics Ltd., as Non-Executive Director.
Mr. Diggle received his graduate degree from the University of Oxford.